phenyl acetate has been researched along with Peritonitis in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (57.69) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 2 (7.69) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Qiao, Y; Yang, B; Yang, H; Zhao, Y | 1 |
| Bian, J; Bo, L; Deng, X; Jiang, Z; Li, N; Wang, C; Xu, M; Zha, Y; Zhang, Y | 1 |
| Forbes, TA; Lunn, AJ | 1 |
| KOTSIUBINSKII, IG | 1 |
| Arrieta, J; Escanero, J; Guerra, M; Moina, I; Soria, M; Ugarte, I | 1 |
| Ammori, BJ; Farooq, A | 1 |
| Ahlmén, J; Stelin, G | 1 |
| Dávid, MF; Farkas, L; Karátson, A; Kocsis, B; Rácz, L | 1 |
| Bammatter, F; Binswanger, U; Heule, H; Keusch, G; Kiss, D | 1 |
| Buéno, L; Julia, V; Mezzasalma, T | 1 |
| Caruso, A; Cutuli, V; Modica, M; Santagati, A; Santagati, M | 1 |
| Campbell, M; Cody, J; Daly, C; Donaldson, C; Fitzhugh, K; Grant, A; Khan, I; Lawrence, P; MacLeod, A; Montague, G; Ritchie, C; Vale, L; Wallace, S | 1 |
| Cerutti, S; Forlani, A; Sperandeo, F | 1 |
| Dobbie, JW | 1 |
| Amico-Roxas, M; Caruso, A; Clementi, G; Cutuli, V; Fiore, CE; Prato, A | 1 |
| Grzegorzewska, AE; Uchman, G | 1 |
| Belardi, P; Beltrame, G; Boero, R; Bonello, F; Guarena, C; Maffei, S; Piccoli, G; Quarello, F; Scalzo, B | 1 |
| Morris, JG; Placko, R; Siegel, JH; Tall, BD; Vary, TC | 1 |
| Novello, AC; Port, FK | 1 |
| Brignon, P; Faller, B; Marichal, JF; Straub, P; Wagner, D | 1 |
| Oreopoulos, DG; Wu, GG | 1 |
| Bardone, MC; Detaille, JY; Ducrot, R; Guyonnet, JC; Julou, L; Laffargue, B | 1 |
| Awata, H; Inukai, T; Komatsu, T; Saito, C; Sakai, Y | 1 |
| Deriabin, II; Lizanets, MN | 1 |
| Awata, H; Hirohashi, A; Inukai, T; Okamoto, T; Saito, C; Yamamoto, H; Yukawa, Y | 1 |
2 review(s) available for phenyl acetate and Peritonitis
| Article | Year |
|---|---|
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
Topics: Acetates; Bicarbonates; Buffers; Cellulose; Costs and Cost Analysis; Dialysis Solutions; Efficiency; Humans; Kidney Failure, Chronic; Membranes, Artificial; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Randomized Controlled Trials as Topic; Renal Dialysis; Time Factors | 1998 |
Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.
Topics: Acetates; Adrenergic beta-Antagonists; Anti-Infective Agents, Local; Catheters, Indwelling; Dialysis Solutions; Fibrin; Fibrinolysis; Fibrosis; Humans; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Sclerosis; Stem Cells | 1992 |
24 other study(ies) available for phenyl acetate and Peritonitis
| Article | Year |
|---|---|
Resolution of Eosinophilic Peritonitis with Hypoalbuminemia by Oral Prednisone Acetate in an Elderly Patient Receiving Continuous Ambulatory Peritoneal Dialysis.
Topics: Acetates; Aged; Humans; Hypoalbuminemia; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prednisone | 2020 |
Acetate attenuates inflammasome activation through GPR43-mediated Ca
Topics: Acetates; Animals; Anti-Inflammatory Agents; Autophagy; Calcium; Cytokines; Endotoxemia; Inflammasomes; Inflammation; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Receptors, G-Protein-Coupled; Signal Transduction; Ubiquitination | 2019 |
Montelukast: a novel therapeutic option in eosinophilic peritonitis.
Topics: Acetates; Adolescent; Cyclopropanes; Eosinophilia; Female; Humans; Leukotriene Antagonists; Peritoneal Dialysis; Peritonitis; Quinolines; Sulfides | 2014 |
[SURGICAL TREATMENT OF GASTRIC BURNS].
Topics: Acetates; Acids; Burns; Burns, Chemical; Gastrectomy; Humans; Hydrochloric Acid; Peritonitis; Postgastrectomy Syndromes; Pyloric Stenosis; Sulfuric Acids | 1963 |
[Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].
Topics: Acetates; Amiloride; Animals; Cadmium; Calcium-Transporting ATPases; Cells, Cultured; Dialysis Solutions; Fibroblasts; Fibrosis; Glucose; Hydrogen-Ion Concentration; Hypertonic Solutions; Interleukin-1; Intracellular Fluid; Ion Transport; Lactates; Peritoneal Dialysis; Peritoneum; Peritonitis; Rats; Rats, Wistar; Sclerosing Solutions; Sclerosis; Sodium-Hydrogen Exchangers | 2004 |
Leukotriene inhibitors in combination with steroids: potential role in the development of primary bacterial peritonitis.
Topics: Acetates; Aged; Anti-Inflammatory Agents; Asthma; Cyclopropanes; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Leukotriene Antagonists; Peritoneal Lavage; Peritonitis; Prednisolone; Quinolines; Sulfides | 2005 |
Abdominal pains during CAPD with acetate buffered dialysate.
Topics: Abdomen; Acetates; Buffers; Humans; Pain; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Solutions | 1983 |
Infection of the abdominal cavity and chronic peritoneal dialysis.
Topics: Acetates; Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Catheters, Indwelling; Escherichia coli Infections; Female; Humans; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Peritonitis; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections | 1981 |
Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate?
Topics: Acetates; Buffers; Humans; In Vitro Techniques; Lactates; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus | 1981 |
Influence of bradykinin in gastrointestinal disorders and visceral pain induced by acute or chronic inflammation in rats.
Topics: Abdominal Pain; Acetates; Acetic Acid; Animals; Bradykinin; Bradykinin Receptor Antagonists; Colon; Gastrointestinal Motility; Male; Peritonitis; Proctitis; Rats; Rats, Wistar; Receptors, Bradykinin; Trinitrobenzenesulfonic Acid | 1995 |
Synthesis of 2,3-dihydro-3-amino-6-phenyl-2-thioxothieno [2,3-d] pyrimidin-4 (1H)-one and of potential antiinflammatory agents 2-aryl-7-phenyl-3H, 9H-pyrimido [2,1-b]thieno-[2',3':4,5]]1,3,4] thiadiazin-9-ones.
Topics: Acetates; Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoquinones; Carrageenan; Edema; Magnetic Resonance Spectroscopy; Pain Measurement; Peritonitis; Pyrimidines; Pyrimidinones; Rats; Spectrophotometry, Infrared; Thiadiazines; Thiophenes | 1994 |
[Anti-edematous, anti-inflammatory and analgesics activity of fentiazac, naproxen and diclofenac sodium].
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Edema; Mice; Naproxen; Peritonitis; Phenylacetates; Pleurisy; Rats; Thiazoles | 1977 |
Survey of electrical resistance of rabbit pinna in experimental peritonitis and peptic ulcer.
Topics: Acetates; Animals; Ear, External; Electric Conductivity; Peptic Ulcer; Peritonitis; Rabbits; Turpentine | 1976 |
Parathyroid hormone fragment 1-34 inhibits drug-induced inflammation in various experimental models.
Topics: Acetates; Acetic Acid; Animals; Carrageenan; Edema; Inflammation; Male; Nystatin; Parathyroid Hormone; Peptide Fragments; Peritonitis; Rats; Rats, Inbred Strains; Serotonin; Substance P; Teriparatide | 1991 |
Net ultrafiltration volume (nUFV) during IPD with acetate or lactate dialysis solutions.
Topics: Acetates; Dialysis Solutions; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Middle Aged; Osmolar Concentration; Peritoneal Dialysis; Peritoneum; Peritonitis; Time Factors; Ultrafiltration | 1990 |
CAPD in a large population: a 7-year experience.
Topics: Acetates; Adult; Aged; Bicarbonates; Dialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Middle Aged; Patient Dropouts; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Survival Analysis; Survival Rate | 1989 |
Effect of dichloroacetate on plasma and hepatic amino acids in sterile inflammation and sepsis.
Topics: Abscess; Acetates; Amino Acids; Animals; Bacteroides Infections; Dichloroacetic Acid; Escherichia coli Infections; Liver; Male; Peritonitis; Rats; Rats, Inbred Strains | 1989 |
Sclerosing encapsulating peritonitis.
Topics: Acetates; Adrenergic beta-Antagonists; Anti-Infective Agents, Local; Bacterial Infections; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Time Factors | 1986 |
Progressive calcifying peritonitis: a new complication of CAPD? Report of two cases.
Topics: Acetates; Aged; Calcinosis; Female; Humans; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Preservation of peritoneal clearance.
Topics: Acetates; Chlorhexidine; Glucose; Humans; Hydrogen-Ion Concentration; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis; Ultrafiltration | 1987 |
[General pharmacological properties of methiazinic acid (16091 RP)].
Topics: Abscess; Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Autonomic Nervous System; Bradykinin; Cardiovascular System; Central Nervous System; Columbidae; Depression, Chemical; Diuresis; Dogs; Edema; Erythema; Exudates and Transudates; Female; Granuloma; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Indomethacin; Mice; Muscles; Peritonitis; Phenothiazines; Phenylbutazone; Rabbits; Radiation-Protective Agents; Rats; Respiratory System; Serotonin Antagonists; Ultraviolet Rays | 1969 |
Anti-inflammatory activities of 1-cinnamoyl-2-methyl-5-methoxy-3-indolylacetic acid (cinmetacin).
Topics: Acetates; Acute Disease; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Body Temperature; Chronic Disease; Cinnamates; Drug Evaluation, Preclinical; Drug Tolerance; Edema; Erythema; Gastrointestinal Hemorrhage; Granuloma; Guinea Pigs; Hyaluronoglucosaminidase; Indoles; Mice; Peritonitis; Protein Denaturation; Rabbits; Rats | 1973 |
[Use of peritoneal dialysis in the treatment of diffuse purulent peritonitis].
Topics: Acetates; Adolescent; Adult; Aged; Catheterization; Female; Humans; Male; Methods; Middle Aged; Penicillins; Peritoneal Dialysis; Peritonitis; Sodium; Solutions; Streptomycin; Suppuration | 1972 |
Synthesis and pharmacology of a new potential anti-inflammatory drug, 1-(3',4'-methylenedioxybenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid (ID-955).
Topics: Acetates; Analgesics; Animals; Anti-Inflammatory Agents; Blood Proteins; Capillary Permeability; Carrageenan; Edema; Erythema; Exudates and Transudates; Fever; Gossypium; Granuloma; Guinea Pigs; Immune Sera; Indoleacetic Acids; Indomethacin; Male; Mice; Oxyphenbutazone; Peritonitis; Protein Denaturation; Radiation-Protective Agents; Rats; Ultraviolet Rays | 1969 |